urea and bisoprolol

urea has been researched along with bisoprolol in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's6 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Hata, M; Hirayama, A; Kunimoto, S; Nakai, T; Sezai, A; Shiono, M; Yoshitake, I1
Furuichi, Y; Sakamoto, A1
Bai, Y; Chen, Q; Feng, C; Ji, T; Qin, Y; Sun, L; Ye, X; Zhao, X; Zhu, J1
Doi, K; Hiruma, T; Inokuchi, R; Nakajima, S; Nakamura, K; Tokunaga, K1
Fujita, M; Godo, S; Kawazoe, Y; Kudo, D; Kushimoto, S; Nomura, R; Ozaki, H; Shimokawa, H1

Reviews

2 review(s) available for urea and bisoprolol

ArticleYear
[Perioperative cardiovascular evaluation and management for noncardiac surgery].
    Masui. The Japanese journal of anesthesiology, 2014, Volume: 63, Issue:3

    Topics: Adrenergic beta-Antagonists; Anesthesia; Atenolol; Bisoprolol; Fatty Acids, Monounsaturated; Fluvastatin; Humans; Indoles; Intraoperative Complications; Metoprolol; Monitoring, Intraoperative; Morpholines; Myocardial Infarction; Myocardial Ischemia; Perioperative Care; Postoperative Complications; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Risk Assessment; Urea

2014
Are beta-blockers effective for preventing post-coronary artery bypass grafting atrial fibrillation? Direct and network meta-analyses.
    Irish journal of medical science, 2016, Volume: 185, Issue:2

    Topics: Adrenergic beta-Antagonists; Atrial Fibrillation; Bayes Theorem; Bisoprolol; Coronary Artery Bypass; Humans; Incidence; Morpholines; Network Meta-Analysis; Randomized Controlled Trials as Topic; Urea

2016

Trials

1 trial(s) available for urea and bisoprolol

ArticleYear
Feasibility of landiolol and bisoprolol for prevention of atrial fibrillation after coronary artery bypass grafting: a pilot study.
    The Journal of thoracic and cardiovascular surgery, 2012, Volume: 144, Issue:5

    Topics: Administration, Oral; Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Anti-Inflammatory Agents; Antioxidants; Arginine; Atrial Fibrillation; Biomarkers; Bisoprolol; C-Reactive Protein; Coronary Artery Bypass; Creatine Kinase, MB Form; Drug Administration Schedule; Fatty Acid Binding Protein 3; Fatty Acid-Binding Proteins; Female; Hemodynamics; Humans; Infusions, Intravenous; Japan; Male; Middle Aged; Morpholines; Natriuretic Peptide, Brain; Pilot Projects; Serum Amyloid P-Component; Single-Blind Method; Time Factors; Treatment Outcome; Troponin I; Urea

2012

Other Studies

3 other study(ies) available for urea and bisoprolol

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Switching therapy from intravenous beta blocker to bisoprolol transdermal patch for atrial fibrillation tachycardia.
    Journal of anesthesia, 2016, Volume: 30, Issue:5

    Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Atrial Fibrillation; Bisoprolol; Blood Pressure; Critical Care; Female; Heart Rate; Humans; Injections, Intravenous; Male; Middle Aged; Morpholines; Retrospective Studies; Transdermal Patch; Urea

2016
Switching Therapy from Intravenous Landiolol to Transdermal Bisoprolol in a Patient with Thyroid Storm Complicated by Decompensated Heart Failure and Gastrointestinal Dysfunction.
    Internal medicine (Tokyo, Japan), 2017, Oct-01, Volume: 56, Issue:19

    Topics: Administration, Cutaneous; Administration, Intravenous; Adrenergic beta-Antagonists; Adult; Atrial Fibrillation; Bisoprolol; Female; Gastrointestinal Diseases; Heart Failure; Humans; Morpholines; Thyroid Crisis; Treatment Outcome; Urea

2017